Program ACTIVE II: Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes

Mary de Groot, Jay H. Shubrook, W. Guyton Hornsby, Yegan Pillay, Kieren Mather, Karen Fitzpatrick, Ziyi Yang, Chandan Saha

Research output: Contribution to journalArticle

Abstract

OBJECTIVE Depression (major depressive disorder [MDD]) in adults with type 2 diabetes mellitus (T2DM) is associated with worsened diabetes complications, increased health care costs, and early mortality. Program ACTIVE II was a randomized, controlled, multicenter treatment trial designed to test the comparative effectiveness of cognitive behavioral therapy (CBT) and/or community-based exercise (EXER) on diabetes and depression outcomes compared with usual care (UC). RESEARCH DESIGN AND METHODS Using a 2×2 factorial randomized controlled trial design, adults with T2DM for ≥1 year who met DSM-IV-TR criteria for MDD were randomized to CBT (10 sessions occurring over 12 weeks; N = 36), EXER (12 weeks of community-based exercise including six sessions with a personal trainer; N = 34), CBT+EXER (concurrent over a 12-week period; N = 34), and UC (N = 36). Primary outcomes were depression remission rate (assessed by psychiatric interviewers blind to assignment) and change in glycemic control (HbA1c). RESULTS Themean age was 56.0 years (SD 10.7). Participants were female (77%), white (71%), and married (52%). After controlling for education and antidepressant use, odds of achieving full MDD remission in the intervention groups were 5.0-6.8 times greater than UC (P < 0.0167). The CBT+EXER group demonstrated improved HbA1c compared with UC. For participants with a baseline HbA1c ≥7.0%, exploratory post hoc subgroup analysis showed that the CBT+EXER group had a 1.1% improvement in HbA1c (P < 0.0001) after controlling for covariates. CONCLUSIONS The Program ACTIVE behavioral treatment interventions demonstrated clinically meaningful improvements in depression outcomes in adults with T2DM and MDD. These community-based interventions are complementary to medical care and extend access to those in rural and urban areas.

Original languageEnglish (US)
Pages (from-to)1185-1193
Number of pages9
JournalDiabetes care
Volume42
Issue number7
DOIs
StatePublished - Jan 1 2019

Fingerprint

Cognitive Therapy
Type 2 Diabetes Mellitus
Major Depressive Disorder
Exercise
Depression
Therapeutics
Diabetes Complications
Diagnostic and Statistical Manual of Mental Disorders
Health Care Costs
Antidepressive Agents
Multicenter Studies
Psychiatry
Research Design
Randomized Controlled Trials
Interviews
Education
Mortality

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Program ACTIVE II : Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes. / de Groot, Mary; Shubrook, Jay H.; Hornsby, W. Guyton; Pillay, Yegan; Mather, Kieren; Fitzpatrick, Karen; Yang, Ziyi; Saha, Chandan.

In: Diabetes care, Vol. 42, No. 7, 01.01.2019, p. 1185-1193.

Research output: Contribution to journalArticle

de Groot, Mary ; Shubrook, Jay H. ; Hornsby, W. Guyton ; Pillay, Yegan ; Mather, Kieren ; Fitzpatrick, Karen ; Yang, Ziyi ; Saha, Chandan. / Program ACTIVE II : Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes. In: Diabetes care. 2019 ; Vol. 42, No. 7. pp. 1185-1193.
@article{b018192865a4403b83d2237279144b8a,
title = "Program ACTIVE II: Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes",
abstract = "OBJECTIVE Depression (major depressive disorder [MDD]) in adults with type 2 diabetes mellitus (T2DM) is associated with worsened diabetes complications, increased health care costs, and early mortality. Program ACTIVE II was a randomized, controlled, multicenter treatment trial designed to test the comparative effectiveness of cognitive behavioral therapy (CBT) and/or community-based exercise (EXER) on diabetes and depression outcomes compared with usual care (UC). RESEARCH DESIGN AND METHODS Using a 2×2 factorial randomized controlled trial design, adults with T2DM for ≥1 year who met DSM-IV-TR criteria for MDD were randomized to CBT (10 sessions occurring over 12 weeks; N = 36), EXER (12 weeks of community-based exercise including six sessions with a personal trainer; N = 34), CBT+EXER (concurrent over a 12-week period; N = 34), and UC (N = 36). Primary outcomes were depression remission rate (assessed by psychiatric interviewers blind to assignment) and change in glycemic control (HbA1c). RESULTS Themean age was 56.0 years (SD 10.7). Participants were female (77{\%}), white (71{\%}), and married (52{\%}). After controlling for education and antidepressant use, odds of achieving full MDD remission in the intervention groups were 5.0-6.8 times greater than UC (P < 0.0167). The CBT+EXER group demonstrated improved HbA1c compared with UC. For participants with a baseline HbA1c ≥7.0{\%}, exploratory post hoc subgroup analysis showed that the CBT+EXER group had a 1.1{\%} improvement in HbA1c (P < 0.0001) after controlling for covariates. CONCLUSIONS The Program ACTIVE behavioral treatment interventions demonstrated clinically meaningful improvements in depression outcomes in adults with T2DM and MDD. These community-based interventions are complementary to medical care and extend access to those in rural and urban areas.",
author = "{de Groot}, Mary and Shubrook, {Jay H.} and Hornsby, {W. Guyton} and Yegan Pillay and Kieren Mather and Karen Fitzpatrick and Ziyi Yang and Chandan Saha",
year = "2019",
month = "1",
day = "1",
doi = "10.2337/dc18-2400",
language = "English (US)",
volume = "42",
pages = "1185--1193",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "7",

}

TY - JOUR

T1 - Program ACTIVE II

T2 - Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes

AU - de Groot, Mary

AU - Shubrook, Jay H.

AU - Hornsby, W. Guyton

AU - Pillay, Yegan

AU - Mather, Kieren

AU - Fitzpatrick, Karen

AU - Yang, Ziyi

AU - Saha, Chandan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - OBJECTIVE Depression (major depressive disorder [MDD]) in adults with type 2 diabetes mellitus (T2DM) is associated with worsened diabetes complications, increased health care costs, and early mortality. Program ACTIVE II was a randomized, controlled, multicenter treatment trial designed to test the comparative effectiveness of cognitive behavioral therapy (CBT) and/or community-based exercise (EXER) on diabetes and depression outcomes compared with usual care (UC). RESEARCH DESIGN AND METHODS Using a 2×2 factorial randomized controlled trial design, adults with T2DM for ≥1 year who met DSM-IV-TR criteria for MDD were randomized to CBT (10 sessions occurring over 12 weeks; N = 36), EXER (12 weeks of community-based exercise including six sessions with a personal trainer; N = 34), CBT+EXER (concurrent over a 12-week period; N = 34), and UC (N = 36). Primary outcomes were depression remission rate (assessed by psychiatric interviewers blind to assignment) and change in glycemic control (HbA1c). RESULTS Themean age was 56.0 years (SD 10.7). Participants were female (77%), white (71%), and married (52%). After controlling for education and antidepressant use, odds of achieving full MDD remission in the intervention groups were 5.0-6.8 times greater than UC (P < 0.0167). The CBT+EXER group demonstrated improved HbA1c compared with UC. For participants with a baseline HbA1c ≥7.0%, exploratory post hoc subgroup analysis showed that the CBT+EXER group had a 1.1% improvement in HbA1c (P < 0.0001) after controlling for covariates. CONCLUSIONS The Program ACTIVE behavioral treatment interventions demonstrated clinically meaningful improvements in depression outcomes in adults with T2DM and MDD. These community-based interventions are complementary to medical care and extend access to those in rural and urban areas.

AB - OBJECTIVE Depression (major depressive disorder [MDD]) in adults with type 2 diabetes mellitus (T2DM) is associated with worsened diabetes complications, increased health care costs, and early mortality. Program ACTIVE II was a randomized, controlled, multicenter treatment trial designed to test the comparative effectiveness of cognitive behavioral therapy (CBT) and/or community-based exercise (EXER) on diabetes and depression outcomes compared with usual care (UC). RESEARCH DESIGN AND METHODS Using a 2×2 factorial randomized controlled trial design, adults with T2DM for ≥1 year who met DSM-IV-TR criteria for MDD were randomized to CBT (10 sessions occurring over 12 weeks; N = 36), EXER (12 weeks of community-based exercise including six sessions with a personal trainer; N = 34), CBT+EXER (concurrent over a 12-week period; N = 34), and UC (N = 36). Primary outcomes were depression remission rate (assessed by psychiatric interviewers blind to assignment) and change in glycemic control (HbA1c). RESULTS Themean age was 56.0 years (SD 10.7). Participants were female (77%), white (71%), and married (52%). After controlling for education and antidepressant use, odds of achieving full MDD remission in the intervention groups were 5.0-6.8 times greater than UC (P < 0.0167). The CBT+EXER group demonstrated improved HbA1c compared with UC. For participants with a baseline HbA1c ≥7.0%, exploratory post hoc subgroup analysis showed that the CBT+EXER group had a 1.1% improvement in HbA1c (P < 0.0001) after controlling for covariates. CONCLUSIONS The Program ACTIVE behavioral treatment interventions demonstrated clinically meaningful improvements in depression outcomes in adults with T2DM and MDD. These community-based interventions are complementary to medical care and extend access to those in rural and urban areas.

UR - http://www.scopus.com/inward/record.url?scp=85068490254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068490254&partnerID=8YFLogxK

U2 - 10.2337/dc18-2400

DO - 10.2337/dc18-2400

M3 - Article

C2 - 31221693

AN - SCOPUS:85068490254

VL - 42

SP - 1185

EP - 1193

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 7

ER -